COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Alpha-1 Antitrypsin Deficiency (a genetic condition that can affect the lungs and liver), including specific genetic types such as PiZZ, PiZNull, and PiSZ, among others.
- People who carry the gene associated with Alpha-1 Antitrypsin Deficiency but may not have the full condition, such as those with genetic types PiMZ or PiMS, among others.
Who may not be able to join:
- People who are not willing or able to give their formal agreement to participate in the trial.
- People who have a normal genetic result for Alpha-1 Antitrypsin (known as MM type) and do not have the deficiency or carry the associated gene.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-228-7321
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Establish the Alpha-1 Research Registry using REDCap
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.